# Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

> **NCT02992886** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 68 (actual)

## Conditions studied

- Rectal Neoplasms Malignant

## Interventions

- **RADIATION:** Preoperative radiation
- **DRUG:** Raltitrexed
- **PROCEDURE:** Pelvic surgery

## Key facts

- **NCT ID:** NCT02992886
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2021-05
- **Final completion:** 2021-08
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2021-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992886, "Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02992886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
